Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector
Highlights • A novel Sendai virus-based vector platform for vaccine developments. • Genome replication deficiency of the vector as contributing factor to safety. • Delivery and display of encoded antigens by two distinct ways. • Induction of a broad humoral response including neutralizing antibodies...
Gespeichert in:
Veröffentlicht in: | Vaccine 2013-08, Vol.31 (37), p.3888-3893 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • A novel Sendai virus-based vector platform for vaccine developments. • Genome replication deficiency of the vector as contributing factor to safety. • Delivery and display of encoded antigens by two distinct ways. • Induction of a broad humoral response including neutralizing antibodies and IgA. • Induction of strong specific cellular immune response including cytokine response. |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2013.06.053 |